HIGHLIGHTS
- who: TYPE and collaborators from the The State of New Jersey, United States have published the research work: Pan-cancer analyses reveal multi-omics and clinical characteristics of RIO kinase 2 in cancer, in the Journal: (JOURNAL)
- what: By describing the function of RIOK2 in pan-cancer, the authors demonstrate that RIOK2 represents a valuable target for treating malignant tumors. To the analysis at the tissue level, the authors used the Wilcox test to compare the expression of RIOK2 at the cellular level in primary and metastatic cell lines; data were obtained from the Cancer . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.